CN Stock MarketDetailed Quotes

002566 Jilin Jian Yisheng Pharmaceutical

Watchlist
  • 6.79
  • -0.15-2.16%
Market Closed Nov 1 15:00 CST
2.25BMarket Cap31.15P/E (TTM)

About Jilin Jian Yisheng Pharmaceutical Company

At the beginning of its establishment, the company set out to “take root in traditional culture, rely on modern technology, and build a complete ginseng industry chain” as its development strategy, aiming to build the number one brand in the Chinese ginseng industry and a first-class brand in the world's ginseng industry. To achieve its strategic goals, the company has built a cultural system with the corporate purpose of “inheriting Chinese civilization and serving human health”; “dedication, teamwork and innovation” as the enterprise spirit; and “caring for all people, honesty and sincerity, putting people first, and putting innovation first” as the core concept. The company's main business is research and development, production and sales of pharmaceuticals. The company's main products include Zhenyuan capsules, Xinyue capsules, fresh hemorrhoid injections, red ginseng and wheat dong cream, red ginseng extract plant drink, Airun, Dayang Hero, Guowei lemon powder, red ginseng, jujube, poria cocos plant drink, Isanio Red Ginseng Nourishing Series, Ginseng Snow Skin Series, Pine Rose Beauty Series, Ginseng Fruit Nourishing Series, Fish Seed Nourishing Series and Gold Recovery Series, Luxury Lotus Luxury Hydrating Series, Luxury Lotus Luxury Hydrating Series, Luxury Lotus Xiuhong series, Luxurious Lotus Xinyang Shuiyuan series, Red ginseng snail series, propolis series, pomegranate series, Wei His Vivid Collection. Corporate honors: In January 2013, Yisheng Pharmaceutical was recognized as the “Advanced Unit for the Revitalization of the Ginseng Industry in Jilin Province”; in May 2013, Yisheng Pharmaceutical was recognized as the “Best Small and Medium Board Enterprise Award”; in January 2015, Yisheng Pharmaceutical was recognized as the “AAA-level Integrity Unit in Jilin Province”; in November 2015, Yisheng Pharmaceutical was recognized as a “contract-abiding and credit-worthy” AAA enterprise in Jilin Province; in July 2016, Yisheng Pharmaceutical was recognized as the “Excellent Model Chinese Medicine AAA Quality Credit Demonstration Unit” in Jilin Province; in July 2016, Yisheng Pharmaceutical was recognized as the “Excellent Model Chinese Medicinal Material” AAA Quality Credit Demonstration Unit in Jilin Province; in July 2016, Yisheng Pharmaceutical was recognized as the “Excellent Model Chinese Medicinal Material” AAA Quality Credit Demonstration Unit in Jilin Province; “Planting base”, national high-tech Honorary title of technology enterprise, title of key leading enterprise in agricultural industrialization at the municipal level, “Tonghua Specialized and New Enterprise”, “National Intellectual Property Advantage Enterprise”, “Cosmetics Production Demonstration Base”, etc.

Company Profile

Short Name-A益盛药业
Symbol-A002566
Company NameJilin Jian Yisheng Pharmaceutical CO.,LTD.
Listing DateMar 18, 2011
Issue Price39.90
Shares Offered27.60M share(s)
FoundedJun 11, 1997
Listed ExchangeSZ Stock Exchange
Legal Representativeyisheng zhang
General Managerxiaomin xue
Secretarytiejun li
Accounting FirmChina Audit Zhonghuan Certified Public Accountants (Special General Partnership)
Securities Representativejing li
Legal CounselBeijing Zhide Law Firm
Employees1370
Phone0435-6236009
Office AddressNo. 17-20, Wenhua East Road, Ji'an City, Jilin Province
Zip Code134200
Registered AddressNo. 17-20, Wenhua East Road, Ji'an City, Tonghua City, Jilin Province
Fax0435-6236009
Emailyisheng@yisheng-pharm.com
Business License220500000001302
BusinessLicense projects: pharmaceutical production; contract manufacturing; pharmaceutical import and export; pharmaceutical wholesale; pharmaceutical retail; cosmetics production; health products (non-food) sales; health food production; food production; health products (non-food) production; special medical formula production; fertilizer production; food internet sales; food sales; beverage production; lifestyle and beauty services; medical and aesthetic services; road cargo transportation (network freight); road dangerous goods transportation. (Projects subject to approval according to law, business activities can only be carried out after approval by relevant departments. Specific business projects are subject to approval documents or licenses from relevant departments) General projects: Chinese herbal medicine cultivation; traditional Chinese medicine extract production; real estate Chinese herbal medicine (excluding Chinese medicine tablets) purchase and sale; cosmetics wholesale; cosmetics retail; internet sales (excluding products that require permission); health food (prepackaging) sales; bio-organic fertilizer research and development; compound microbial fertilizer research and development; fertilizer sales; food import and export; special medical health care products sales (non-traditional Chinese medicine health care products) Healthcare); TCM Clinic Services (only business activities can be carried out after registration by the competent department of traditional Chinese medicine); management of traditional spice products; food sales (sale of prepackaged food only); technical services, technology development, technical consultation, technical exchange, technology transfer, technology promotion; development and application of human stem cell technology; non-residential real estate leasing; machinery and equipment leasing. (With the exception of projects subject to approval according to law, business activities are carried out independently in accordance with the law on the basis of a business license)

Company Executives

  • Name
  • Position
  • Salary
  • yisheng zhang
  • Chairman, Directors, Chairman of the Strategy Committee
  • 1.05M
  • xin zhang
  • Vice Chairman, Directors, Member of the Strategy Committee
  • 143.40K
  • xiaole tong
  • Directors, Nomination Committee Members
  • 279.00K
  • jianjun qu
  • Directors, Member of the Remuneration and Assessment Committee
  • 248.40K
  • jiantao bi
  • Directors, Deputy General Manager, Chief Financial Officer, Member of the Strategy Committee
  • 527.30K
  • he wang
  • Directors, Audit Committee Member
  • 279.00K
  • lirong sun
  • Independent Directors, Audit Committee Member, Chairman of the Remuneration and Assessment Committee, Nomination Committee Members
  • 50.00K
  • ming li
  • Independent Directors, Chairman of the Audit Committee, Member of the Strategy Committee, Member of the Remuneration and Assessment Committee
  • 50.00K
  • qibin chen
  • Independent Directors, Member of the Strategy Committee, Chairman of the Nomination Committee
  • 33.30K
  • tiejun li
  • Board Secretary, Deputy General Manager
  • 538.10K
  • jing li
  • Securities Affairs Representative
  • --
  • xiaojing yu
  • Chairman of the Supervisory Board, Employee Supervisors
  • 149.20K
  • junyan ye
  • Auditors
  • 110.00K
  • yuchun fang
  • Auditors
  • 149.40K
  • xiaomin xue
  • General Manager, Core Technical Personnel
  • 717.40K
  • wei meng
  • Deputy General Manager
  • 536.40K
  • li yang
  • Assistant to the General Manager
  • 20.00K
  • manli qu
  • Head of Internal Audit
  • 43.20K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data